FDA Inspection 1228195 — Nartex Laboratorios Homeopaticos S.A. de C.V.
The FDA completed an inspection of Nartex Laboratorios Homeopaticos S.A. de C.V. on December 15, 2023 in Torreon. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- December 15, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Torreon (Mexico)